More Immutep Ltd news Immutep LtdASX: IMM Immutep doses First Patient in TACTI-002 Phase II Trial Mar 6, 2019 at 12:21 PM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
